Header Logo

Connection

Gary Schaer to Humans

This is a "connection" page, showing publications Gary Schaer has written about Humans.
Connection Strength

0.537
  1. a-Gal Nanoparticles Mediated Homing of Endogenous Stem Cells for Repair and Regeneration of External and Internal Injuries by Localized Complement Activation and Macrophage Recruitment. Int J Mol Sci. 2022 Sep 29; 23(19).
    View in: PubMed
    Score: 0.045
  2. Advances in our Understanding and Treatment of the No-Reflow Phenomenon After PCI for STEMI. Cardiovasc Revasc Med. 2022 04; 37:102-104.
    View in: PubMed
    Score: 0.043
  3. Marital Status and Cardiovascular Health: Is There a Link? Cardiovasc Revasc Med. 2018 Apr - May; 19(3 Pt B):A3-A4.
    View in: PubMed
    Score: 0.033
  4. Left ventricular perforation in a patient with a left ventricular aneurysm during NOGA? catheter mapping. Cardiovasc Revasc Med. 2018 12; 19(8S):50-52.
    View in: PubMed
    Score: 0.031
  5. Clinical Benefits of Stem Cells for Chronic Symptomatic Systolic Heart Failure: A Systematic Review of the Existing Data and Ongoing Trials. Cell Transplant. 2016 11; 25(11):1911-1923.
    View in: PubMed
    Score: 0.030
  6. Adverse outcomes in hospitalized patients who develop ST-elevation myocardial infarction. Crit Pathw Cardiol. 2014 Jun; 13(2):62-5.
    View in: PubMed
    Score: 0.025
  7. Assessment of safety, accuracy, and human CD34+ cell retention after intramyocardial injections with a helical needle catheter in a porcine model. Catheter Cardiovasc Interv. 2013 May; 81(6):970-7.
    View in: PubMed
    Score: 0.023
  8. Therapeutic angiogenesis for the management of refractory angina: current concepts. Cardiovasc Ther. 2011 Dec; 29(6):e1-e11.
    View in: PubMed
    Score: 0.019
  9. Erosion of an extrapericardial implantable cardioverter defibrillator patch through the gastric fundus with fistulous tract formation. Cardiol Rev. 2006 Nov-Dec; 14(6):e21-3.
    View in: PubMed
    Score: 0.015
  10. Clinical and angiographic outcomes of cardiac transplant patients treated with intracoronary beta-radiation for in-stent restenosis: a case series. Cardiovasc Radiat Med. 2004 Oct-Dec; 5(4):162-5.
    View in: PubMed
    Score: 0.013
  11. Noncardiac applications of glycoprotein IIb/IIIa inhibitors. Catheter Cardiovasc Interv. 2004 Aug; 62(4):530-8.
    View in: PubMed
    Score: 0.013
  12. Use of corticosteroids in the treatment of cholesterol crystal embolization after percutaneous transluminal coronary angioplasty and stent placement. J Invasive Cardiol. 2004 Apr; 16(4):222-3.
    View in: PubMed
    Score: 0.012
  13. Intracoronary beta brachytherapy as a treatment option for high-risk refractory in-stent restenosis; Compassionate use. Cardiovasc Radiat Med. 2004 Jan-Mar; 5(1):9-14.
    View in: PubMed
    Score: 0.012
  14. Mechanisms behind intracoronary radiation therapy failure. J Am Coll Cardiol. 2003 Jul 16; 42(2):395-6; author reply 396.
    View in: PubMed
    Score: 0.012
  15. Correlates of failure following treatment with Sr-90 beta irradiation for in-stent restenosis. Catheter Cardiovasc Interv. 2003 Jun; 59(2):176-83.
    View in: PubMed
    Score: 0.012
  16. Predictors of late cardiac events following treatment with Sr-90 beta-irradiation for instent restenosis. Cardiovasc Radiat Med. 2003 Jan-Mar; 4(1):7-11.
    View in: PubMed
    Score: 0.011
  17. Visual assessment of procedural results following treatment with Sr-90 beta-radiation for instent restenosis. Cardiovasc Radiat Med. 2002 Jul-Dec; 3(3-4):133-7.
    View in: PubMed
    Score: 0.011
  18. Utility of Guide Extension Catheter for Rotational Atherectomy Through a?LIMA?Graft. JACC Cardiovasc Interv. 2022 01 10; 15(1):e1-e2.
    View in: PubMed
    Score: 0.010
  19. If invasive functional testing is so great, why aren't we doing it routinely? Catheter Cardiovasc Interv. 2001 May; 53(1):39.
    View in: PubMed
    Score: 0.010
  20. Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials. Eur Heart J. 2018 06 14; 39(23):2208-2216.
    View in: PubMed
    Score: 0.008
  21. PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMI. Circ Res. 2017 Jan 20; 120(2):324-331.
    View in: PubMed
    Score: 0.007
  22. The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34(+) Cell Administration in Patients With Refractory Angina. JACC Cardiovasc Interv. 2016 08 08; 9(15):1576-85.
    View in: PubMed
    Score: 0.007
  23. Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarction. Results of a randomized, double-blind, placebo-controlled trial. Circulation. 1996 Aug 01; 94(3):298-307.
    View in: PubMed
    Score: 0.007
  24. Duration of Dual Antiplatelet Therapy in Coronary Artery Disease: a Review Article. Curr Atheroscler Rep. 2016 Jul; 18(7):45.
    View in: PubMed
    Score: 0.007
  25. Comparative Analysis of Radial Versus Femoral Diagnostic Cardiac Catheterization Procedures in a Cardiology Training Program. J Invasive Cardiol. 2016 Jun; 28(6):254-7.
    View in: PubMed
    Score: 0.007
  26. Autologous CD34+ Cell Therapy for Refractory Angina: 2-Year Outcomes From the ACT34-CMI Study. Cell Transplant. 2016; 25(9):1701-1711.
    View in: PubMed
    Score: 0.007
  27. Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial. Lancet. 2016 Jun 11; 387(10036):2412-21.
    View in: PubMed
    Score: 0.007
  28. The ixCELL-DCM Trial: Rationale and Design. Cell Transplant. 2016; 25(9):1689-1699.
    View in: PubMed
    Score: 0.007
  29. Impact of a novel interventional platform and hospital design on the door-to-balloon time in patients presenting with ST-segment elevation myocardial infarction. Crit Pathw Cardiol. 2015 Mar; 14(1):39-43.
    View in: PubMed
    Score: 0.007
  30. Successful collaborative model for STEMI care between a STEMI-referral and a STEMI receiving center. Crit Pathw Cardiol. 2014 Dec; 13(4):131-4.
    View in: PubMed
    Score: 0.007
  31. A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: design of the RENEW study. Am Heart J. 2013 Jun; 165(6):854-861.e2.
    View in: PubMed
    Score: 0.006
  32. An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure. Circ Res. 2013 Mar 01; 112(5):816-25.
    View in: PubMed
    Score: 0.006
  33. Achieving high quality in ST-segment elevation myocardial infarction care: one urban academic medical center experience. Crit Pathw Cardiol. 2012 Mar; 11(1):32-9.
    View in: PubMed
    Score: 0.005
  34. Outcomes of unselected recipients of sirolimus-eluting stents: the Cypher stent U.S. post-marketing surveillance registry. J Invasive Cardiol. 2010 Feb; 22(2):48-55.
    View in: PubMed
    Score: 0.005
  35. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol. 2009 Dec 08; 54(24):2277-86.
    View in: PubMed
    Score: 0.005
  36. Myocardial infarction after taking zolmitriptan. Yale J Biol Med. 2005 May; 78(3):147-50.
    View in: PubMed
    Score: 0.003
  37. Long-term (2-year) clinical events following transthoracic intramyocardial gene transfer of VEGF-2 in no-option patients. J Interv Cardiol. 2005 Feb; 18(1):27-31.
    View in: PubMed
    Score: 0.003
  38. Clinical and angiographic profile of patients with markedly elevated coronary calcium scores (>or=1000) detected by electron beam computed tomography. Cardiovasc Radiat Med. 2004 Jul-Sep; 5(3):109-12.
    View in: PubMed
    Score: 0.003
  39. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA. 2003 Nov 05; 290(17):2284-91.
    View in: PubMed
    Score: 0.003
  40. Pharmacoinvasive management of acute coronary syndrome in the setting of percutaneous coronary intervention: evidence-based, site- and spectrum-of-care strategies for optimizing patient outcomes in NSTE-ACS. J Invasive Cardiol. 2003 Sep; 15(9):536-53.
    View in: PubMed
    Score: 0.003
  41. One-year follow-up of direct myocardial gene transfer of vascular endothelial growth factor-2 using naked plasmid deoxyribonucleic acid by way of thoracotomy in no-option patients. Am J Cardiol. 2003 Aug 15; 92(4):436-9.
    View in: PubMed
    Score: 0.003
  42. Usefulness of beta radiation for de novo and in-stent restenotic lesions in saphenous vein grafts. Am J Cardiol. 2003 Aug 01; 92(3):312-4.
    View in: PubMed
    Score: 0.003
  43. Aortic homograft endocarditis caused by Rhodotorula mucilaginosa. Infection. 2003 Jun; 31(3):181-3.
    View in: PubMed
    Score: 0.003
  44. Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction. J Am Coll Cardiol. 2002 Dec 04; 40(11):1928-34.
    View in: PubMed
    Score: 0.003
  45. The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. J Am Coll Cardiol. 2002 Jan 02; 39(1):30-6.
    View in: PubMed
    Score: 0.003
  46. Clinical outcomes of patients treated with the cutting balloon and Sr-90 beta-irradiation for instent restenosis. Cardiovasc Radiat Med. 2002 Jan-Mar; 3(1):12-5.
    View in: PubMed
    Score: 0.003
  47. Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure? Circulation. 2001 Aug 14; 104(7):779-82.
    View in: PubMed
    Score: 0.003
  48. Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trial. Potential Class Improvement From Intramyocardial Channels. Lancet. 2000 Nov 18; 356(9243):1705-10.
    View in: PubMed
    Score: 0.002
  49. Determinants of infarct size after thrombolytic treatment in acute myocardial infarction. Am J Cardiol. 1999 Jun 15; 83(12):1600-5.
    View in: PubMed
    Score: 0.002
  50. Value of the American College of Cardiology/American Heart Association stenosis morphology classification for coronary interventions in the late 1990s. Am J Cardiol. 1998 Jul 01; 82(1):43-9.
    View in: PubMed
    Score: 0.002
  51. Does low individual operator coronary interventional procedural volume correlate with worse institutional procedural outcome? J Am Coll Cardiol. 1997 Oct; 30(4):870-7.
    View in: PubMed
    Score: 0.002
  52. Poloxamer-188 as an adjunct to primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol. 1996 Oct 01; 78(7):747-50.
    View in: PubMed
    Score: 0.002
  53. Excimer laser ablation before autoperfusion balloon inflation: a novel therapeutic approach to high grade stenoses in vessels supplying substantial myocardium at risk. Cathet Cardiovasc Diagn. 1992 Nov; 27(3):202-8.
    View in: PubMed
    Score: 0.001
  54. Detection of renal blood flow abnormalities in septic and critically ill patients using a newly designed indwelling thermodilution renal vein catheter. Chest. 1990 Jul; 98(1):170-9.
    View in: PubMed
    Score: 0.001
  55. A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med. 1989 Oct 19; 321(16):1061-8.
    View in: PubMed
    Score: 0.001
  56. Assessment of residual coronary arterial stenosis after thrombolytic therapy during acute myocardial infarction. Am J Cardiol. 1987 Jun 01; 59(15):1231-3.
    View in: PubMed
    Score: 0.001
  57. The coronary circulation in human septic shock. Circulation. 1986 Apr; 73(4):637-44.
    View in: PubMed
    Score: 0.001
  58. Evaluation of a long-acting converting enzyme inhibitor (enalapril) for the treatment of chronic congestive heart failure. J Am Coll Cardiol. 1983 Apr; 1(4):1154-9.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.